Tine Bekaert is a senior investment manager at PMV (ParticipatieMaatschappij Vlaanderen), where she focuses on the financing of start-ups active in the life sciences & care sector. Currently, Tine is a member of the Board of Directors of Flamingo Therapeutics, Dualyx, Rewind Therapeutics and Nobi. Tine holds a PhD in Biotechnology from Ghent University (Belgium) and has been involved in different European research infrastructure programs in the life sciences sector. Prior to PMV, Tine worked as a senior manager at Deloitte, where she managed a team responsible for strategic advice on grants and tax incentives for R&D and innovation
